DIVIS LABORATORIES
Back to Balance Sheet
|
DIVIS LABORATORIES Last 5 Year Capital Work in Progress History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Capital Work in Progress | ₹1,022 Cr | ₹778 Cr | ₹212 Cr | ₹470 Cr | ₹711 Cr |
What is the latest Capital Work in Progress ratio of DIVIS LABORATORIES ?
| Year | Capital Work in Progress |
|---|---|
| Mar2025 | ₹1,022 Cr |
| Mar2024 | ₹778 Cr |
| Mar2023 | ₹212 Cr |
| Mar2022 | ₹470 Cr |
| Mar2021 | ₹711 Cr |
How is Capital Work in Progress of DIVIS LABORATORIES Trending?
| Years | Capital Work in Progress | % Change | |
|---|---|---|---|
| Mar2025 | ₹1,022 Cr | 31.36 | |
| Mar2024 | ₹778 Cr | 266.98 | |
| Mar2023 | ₹212 Cr | -54.89 | |
| Mar2022 | ₹470 Cr | -33.87 | |
| Mar2021 | ₹711 Cr | - | |
Compare Capital Work in Progress of peers of DIVIS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DIVIS LABORATORIES | ₹170,597.0 Cr | -0.8% | -0.8% | 8.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹412,590.0 Cr | -2% | -6.1% | -6.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹129,301.0 Cr | 0% | 2.7% | 11% | Stock Analytics | |
| CIPLA | ₹120,471.0 Cr | -0.6% | -2.6% | 0.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,660.0 Cr | -1.3% | 0.6% | -6.4% | Stock Analytics | |
| MANKIND PHARMA | ₹88,885.2 Cr | -3.5% | -4.4% | -25.1% | Stock Analytics | |
DIVIS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DIVIS LABORATORIES | -0.8% |
-0.8% |
8.7% |
| SENSEX | -1% |
-1.2% |
7.9% |
You may also like the below Video Courses